by Susan Horton
Johnson and Johnson just announced last week plans to test Ebola vaccine in 20,000 humans this January and could have a quarter million doses available by springtime. Alex Gorsky CEO, Johnson and Johnson says, “We absolutely think this is a critical first step in the war against Ebola. We have been working on this for some time now. As often is the case with science it’s a little bit of knowledge, then you have a hypothesis and then you test it out.
Our scientist have made a lot of progress by taking a very focused approach with one of our vaccines produced out of Crucell, Netherlands unit and combining it with another companies vaccine. This consists of two injections; one to prime the immune system and a second to Boost the response, a one two punch.”
They were given 2 months apart in the Monkey tests and the combination provided (complete protection) in the animals. Researchers are now testing a single shot of GSK’s vaccine. Johnson & Johnson is developing the vaccine with the Danish biotech company Bavarian Nordic.
Continue Reading at PatriotUpdate.com